ArticleBasic and clinical andrology2025
Quercetin ameliorates nicotine-induced spermatogenesis damage via modulation of sperm miR-151a-5p and testicular Cep72 gene expression.
Article in Basic and clinical andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSmoking impairs spermatogenesis by disrupting gene and miRNA expression profiles. This study aims to explore the protective effects of quercetin against nicotine-induced testicular damage, with a specific focus on its regulatory role on sperm miR-151a-5p and testicular Cep72 gene expression, as potential molecular mechanisms involved in male reproductive dysfunction. Male BALB/c mice (N = 32) were randomly divided into four groups of: control, nicotine, quercetin, and quercetin + nicotine combined groups. Treatments lasted 35 days. Spermatogenesis was evaluated through histopathological studies of the testicles. TAC and SOD levels were evaluated as markers of antioxidant activity using colorimetric methods in testicular homogenates. Sex hormones were measured using the ELISA method. Relative expression of Cep72 and miR-151a-5p genes in testicular tissue and epididymal sperm was assessed by real-time PCR. Androgen receptor (AR) and estrogen receptor alpha (ERα) expression in testicular tissue were evaluated by immunohistochemical methods.
resultsThe combined treatment of quercetin and nicotine enhanced sperm quality, caused significant changes in LH and estradiol hormone levels, increased anti-oxidants in testicular homogenates, and increased AR expression in Sertoli cells without affecting ERα, compared to the nicotine group. In addition, the combined therapy improved spermatogenesis by increasing the number of germ cells and Leydig cells. Furthermore, combined therapy increased testicular Cep72 gene expression and reduced sperm miR-151a-5p.
conclusionsThis study demonstrates that quercetin may protect against nicotine-induced testicular damage by maintaining hormonal balance, enhancing AR expression, improving antioxidant enzyme activity, and normalizing the miR-151a-5p/Cep72 regulatory axis, ultimately supporting sperm quality and spermatogenesis. These results establish a foundation for future mechanistic and translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.